CRL FY 2007 Earnings Report — Charles River Laboratories International, Inc. Revenue & Financial Results | Market Cap Arena

Charles River Laboratories International, Inc.CRL

FY 2007 Earnings

Reported February 20, 2008

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2007	Prior Q	FY 2006	QoQ Change	YoY Change
Revenue	$1.2B	—	$1.1B	—	16.3%
Op. Income	$227M	—	$188M	—	20.7%
Gross Margin	38.9%	—	38.4%	—	0.4pp
Net Margin	12.5%	—	-5.3%	—	17.8pp
EPS (Diluted)	$2.25	—	$-0.80	—	381.2%
Free Cash Flow	$57M	—	-$17M	—	429.2%

Revenue Flow

Item	Amount
REVENUE	$1.2B
Cost of Revenue	$752M
GROSS PROFIT	$478M
R&D Expenses	$0
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$217M
Other Expenses	$34M
Operating Expenses	$251M
Cost & Expenses	$1.0B
OPERATING INCOME	$227M
Interest Income	$10M
Interest Expense	$15M
Other Income/Expenses	-$10M
INCOME BEFORE TAX	$217M
Income Tax Expense	$59M
Net Income from Continuing Ops	$158M
Net Income from Discontinued Ops	$0
Other Adjustments	-$3M
NET INCOME	$154M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$154M
D&A	$86M
EBIT	$235M
EBITDA	$322M
EPS	$2
EPS Diluted	$2

Income Statement

Item	Amount
REVENUE	$1.2B
Cost of Revenue	$752M
GROSS PROFIT	$478M
R&D Expenses	$0
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$217M
Other Expenses	$34M
Operating Expenses	$251M
Cost & Expenses	$1.0B
OPERATING INCOME	$227M
Interest Income	$10M
Interest Expense	$15M
Other Income/Expenses	-$10M
INCOME BEFORE TAX	$217M
Income Tax Expense	$59M
Net Income from Continuing Ops	$158M
Net Income from Discontinued Ops	$0
Other Adjustments	-$3M
NET INCOME	$154M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$154M
D&A	$86M
EBIT	$235M
EBITDA	$322M
EPS	$2
EPS Diluted	$2

Cash Flow Statement

Item	Amount
Net Income	$154M
Depreciation & Amortization	$89M
Stock-Based Compensation	$0
Deferred Income Tax	-$10M
Other Non-Cash Items	$10M
Change in Working Capital	$19M
OPERATING CASH FLOW	$284M
Capital Expenditure	-$227M
Acquisitions (Net)	-$12M
Purchases of Investments	-$299M
Sales/Maturities of Investments	$335M
Other Investing Activities	$3M
NET CASH FROM INVESTING	-$201M
Net Debt Issuance	-$65M
Common Stock Repurchased	-$42M
Common Dividends Paid	$0
Other Financing Activities	$6M
NET CASH FROM FINANCING	-$46M
FREE CASH FLOW	$57M
Net Change in Cash	$50M

Balance Sheet

Item	Amount
Cash & Equivalents	$225M
Short-Term Investments	$15M
Net Receivables	$214M
Inventory	$88M
Other Current Assets	$32M
TOTAL CURRENT ASSETS	$608M
PP&E (Net)	$749M
Goodwill	$1.1B
Intangible Assets	$149M
Long-Term Investments	$0
Tax Assets	$89M
Other Non-Current Assets	$90M
TOTAL NON-CURRENT ASSETS	$2.2B
TOTAL ASSETS	$2.8B
Account Payables	$37M
Short-Term Debt	$25M
Deferred Revenue	$102M
Other Current Liabilities	$24M
TOTAL CURRENT LIABILITIES	$303M
Long-Term Debt	$485M
Deferred Revenue NC	$0
Deferred Tax Liabilities	$71M
Other Non-Current Liabilities	$83M
TOTAL NON-CURRENT LIABILITIES	$639M
TOTAL LIABILITIES	$942M
Common Stock	$754.0K
Additional Paid-In Capital	$1.9B
Retained Earnings	$178M
Treasury Stock	-$310M
Accum. Other Comp. Income	$86M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$1.9B
Minority Interest	$4M
TOTAL EQUITY	$1.9B
TOTAL LIABILITIES & EQUITY	$2.8B
Total Debt	$510M
Net Debt	$285M